1. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J, Sawitsky A, Rosner F, Gussoff B, Silver RT, Karanas A, Cuttner J, Spurr CL, Hayes DM, Blom J, Leone LA, Haurani F, Kyle R, Hutchison JL, Forcier RJ, Moon JH: Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults. Blood 32:507–523, 1968.
2. Boggs DR, Wintrobe MM, Cartwright GE. The acute leukemias: Analysis of 322 cases and review of the literature. Medicine 41:163–225, 1962.
3. Vogler WR, Huguley CM Jr, Rundles RW: Comparison of methotrexate with 6-mercaptopurine-prednisone in treatment of acute leukemia in adults. Cancer 20:1221–1226, 1967.
4. Ellison RR, Hoogstraten B, Holland JF, Levy RN, Lee SL, Silver RT, Leone LA, Cooper T, Oberfield RA, Pas A, Blom J, Jacquillet C, Haurani F: Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. Cancer Chemo Rep 56:535–542, 1972.
5. Thompson I, Hall TC, Maloney WC: Combination therapy of adult and acute myelogenous leukemia: Experience with the simultaneous use of vincristine, amethopterin, 6-mercaptopurine and prednisone. N Engl J Med 273:1302–1307, 1965.